Paradice Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

Paradice Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$30.5M	Sell	2,024,014 -18,411	-0.9%	-$321K	4.87%	13
2026 Q1	$39.2M	Sell	2,042,425 -35,320	-2%	-$767K	7.35%	3
2025 Q4	$45.7M	Sell	2,077,745 -118,723	-5%	-$2.14M	8.89%	2
2025 Q3	$26.7M	Buy	2,196,468 +429,289	+24%	+$5.81M	5.98%	9
2025 Q2	$32.9M	Buy	1,767,179 +117,272	+7%	+$2.32M	6.69%	4
2025 Q1	$31.6M	Buy	1,649,907 +693,500	+73%	+$20.3M	7.06%	4
2024 Q4	$34.4M	Buy	956,407 +52,966	+6%	+$1.79M	6.83%	4
2024 Q3	$38.3M	Buy	903,441 +81,448	+10%	+$3.45M	6.67%	3
2024 Q2	$33.1M	Hold	821,993	–	–	5.86%	4
2024 Q1	$29.1M	Sell	821,993 -259,893	-24%	-$6.96M	5.05%	8
2023 Q4	$32M	Sell	1,081,886 -438,179	-29%	-$9.09M	4.02%	10
2023 Q3	$31.6M	Buy	1,520,065 +293,250	+24%	+$8.05M	2.71%	20
2023 Q2	$30.1M	Buy	+1,226,815	New	+$39.5M	2.24%	22

Other funds holding TNDM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

FGP

Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return

Paradice Investment Management's TNDM Position: Q2 2026 in Review

Paradice Investment Management reduced its Tandem Diabetes Care (TNDM) stake by 0.9% in Q2 2026, selling an estimated $321K and leaving 2,024,014 shares worth $30.5M. The position accounts for 4.87% of the portfolio, ranked #13.

Paradice Investment Management first reported a position in TNDM in Q2 2023 and has held it in 13 quarters since. The position peaked at $45.7M in Q4 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

Paradice Investment Management held 2,024,014 shares of Tandem Diabetes Care worth $30.5M as of Q2 2026.
Paradice Investment Management sold 18,411 Tandem Diabetes Care shares in Q2 2026, an estimated $321K.
Tandem Diabetes Care made up 4.87% of Paradice Investment Management's portfolio in Q2 2026, its #13 holding.
Paradice Investment Management first reported a position in Tandem Diabetes Care in Q2 2023 and has held it in 13 quarters since.
Paradice Investment Management's Tandem Diabetes Care position peaked at $45.7M in Q4 2025.
274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Paradice Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.